Last reviewed · How we verify
Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer
The purpose of this clinical research is to establish a multi-omics model based on genomics，transcriptomics，gut microbiota in predicting pathologic response after neoadjuvant chemoradiotherapy combined PD-1 antibody given to patients with locally advanced rectal cancer.
Details
| Lead sponsor | Beijing Friendship Hospital |
|---|---|
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Colorectal Neoplasms
Interventions
- long course radiotherapy + capecitabine + PD-1 monoclonal antibody
Countries
China